Pulling SEC filings + quote and writing the call…

Esquire Financial Holdings, Inc.
Next earnings Jul 22, 2026 · consensus $1.59 EPS, $42.0M rev
Last earnings +4.3% on 2026-04-23
Niche legal-industry bank compounding earnings ~16%/yr at 17.5% ROE — 19.7x P/E is fair, not cheap, for this quality.
Quality fundamentals and an attractive price line up (~64% below fair value) — the rarer case where both the business and the entry look good.
Esquire is a specialty commercial bank built around the U.S. legal industry — a defensible niche that has translated into compounding fundamentals: net income has grown from $17.9M in FY2021 to $50.8M in FY2025 (a ~30% CAGR), with FY2025 alone up 16.4% YoY and diluted EPS up 14.2% to $5.87. Total assets jumped 25% to $2.37B while stockholders' equity grew 22.1% to $290M, and retained earnings climbed 29.3% — the balance sheet is being built with internally generated capital rather than dilution (shares up only 2.4%). A 17.5% ROE in commercial banking is top-decile, and operating cash flow of $59.8M (+41.8%) comfortably exceeds reported net income, supporting earnings quality.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $17.9M | $28.5M | $41.0M | $43.7M | $50.8M |
| Diluted EPS | $2.26 | $3.47 | $4.91 | $5.14 | $5.87 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results; routine other event disclosure
Other event disclosure with exhibits; likely dividend or routine update
Annual meeting shareholder vote results disclosed
Q1 2026 results; continued growth on $2.37B asset base, 17.5% ROE
2026 proxy: director slate, exec comp and auditor ratification
2026 proxy: director slate, exec comp and auditor ratification
Q1 2026 earnings release and investor materials disclosed
Executive officer/director change announced with related exhibits
FY25 NI $50.8M (+16%), EPS $5.87, assets +25%; clean audit opinion
Sources: SEC EDGAR (CIK 0001531031, latest 10-Q filed 2026-05-11) · EODHD · analysis by claude-code · as of 6/25/2026, 2:24:14 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-03-19 | Powers Richard T Director | Sell | 2.31K @ $104.83 | $242K |
| 2026-03-19 | ZISES SELIG Director | Sell | 2.00K @ $105.25 | $211K |
| 2026-03-19 | ZISES SELIG Director | Sell | 3.00K @ $105.00 | $315K |
| 2026-03-18 | ZISES SELIG Director | Sell | 8.50K @ $107.00 | $910K |
| 2026-03-18 | ZISES SELIG Director | Sell | 2.00K @ $105.54 | $211K |
| 2026-03-18 | ZISES SELIG Director | Sell | 2.00K @ $106.04 | $212K |
| 2026-03-18 | ZISES SELIG Director | Sell | 1.50K @ $105.11 | $158K |
| 2026-03-18 | ZISES SELIG Director | Sell | 2.00K @ $105.16 | $210K |
| 2026-03-18 | ZISES SELIG Director | Sell | 1.50K @ $106.08 | $159K |
| 2026-03-18 | ZISES SELIG Director | Sell | 1.50K @ $107.01 | $161K |
| 2026-03-18 | ZISES SELIG Director | Sell | 2.00K @ $107.13 | $214K |
| 2026-03-18 | ZISES SELIG Director | Sell | 3.00K @ $107.25 | $322K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.